Selective tumor hypoxia targeting by hypoxia-activated prodrug TH-302 inhibits tumor growth in preclinical models of cancer.
published in: Clinical Cancer Research
date of publication: 2011-12-19
language: English
main subject: hypoxia
Cites articles
There is nothing here
Article - wd:Q39425368